Haemonetics (HAE) Net Margin (2009 - 2026)

Haemonetics' Net Margin history runs 18 years deep, the most recent figure standing at 5.82% for Q1 2026.

• On a quarterly basis, Net Margin fell 2336.0% year-over-year to 5.82% in Q1 2026; TTM through Mar 2026 was 7.3%, a 503.0% decrease from a year earlier, with the FY2026 full-year figure at 7.29%, down 503.0% from the prior year.
• Net Margin slipped to 5.82% in Q1 2026 per HAE's latest filing, from 13.2% in the prior quarter.
• Across five years, Net Margin topped out at 17.54% in Q1 2025 and bottomed at 5.82% in Q1 2026.
• The 5-year median for Net Margin is 10.2% (2025), against an average of 9.3%.
• Across the five-year window, Net Margin soared 1159 bps in 2025 and plunged 2336 bps in 2026, its largest moves.
• Year by year, Net Margin stood at 10.79% in 2022, then dropped by 14 bps to 9.29% in 2023, then rose by 16 bps to 10.76% in 2024, then rose by 23 bps to 13.2% in 2025, then tumbled by 144 bps to 5.82% in 2026.
• Per Business Quant, the three latest HAE Net Margin figures stand at 5.82% (Q1 2026), 13.2% (Q4 2025), and 11.82% (Q3 2025).